Table 1 Characteristics of patients undergoing hemodialysis (HD, n = 35) and after kidney transplantation (KT, n = 35). Data are given as %(n) or mean ± standard deviation, [range]

40 % (14)

43 % (15)

>0.05

56.4 ± 11.1 (29–79)

55.8 ± 10.9 (35–78)

>0.05

Smoking habits

Smoker

17.6 % (6/34)

10 % (3/30)

>0.05

Non-smoker

82.4 % (28/34)

90 % (27/30)

Causal underlying disease

Polycystic kidney

8.6 % (3)

11.4 % (4)

>0.05

Unknown

5.7 % (2)

22.9 % (8)

Glomerulonephritis

28.6 % (10)

51.4 % (18)

Diabetic nephropathy

14.3 % (5)

2.9 % (1)

Others

42.8 % (15)

11.4 % (4)

Co-morbidities

Diabetes

14.3 % (5)

14.3 % (5)

>0.05

CHD

62.9 % (22)

28.6 % (10)

Arterial hypertension

94.3 % (33)

74.3 % (26)

Pulmonary disease

28.6 % (10)

14.3 % (5)

Tumor

25.7 % (9)

8.6 % (3)

Osteoporosis

11.4 % (4)

17.1 % (6)

Time after KT

Years

-

14.1 ± 7.1 [4–30]

-

>1 to 5 years

11.4 % (4)

>5 years

88.4 % (31)

Time undergoing HD

Years

5.5 ± 6.4 [1–36]

-

-

<1 year

13.3 %

>1 to 5 years

38.2 % (13)

>5 years

35.3 % (12)

Immunosuppressive medication

Tacrolimus (Prograf)

-

11 % (4)

-

Tacrolimus (Advagraf)

26 % (9)

Cyclosporin A

34 % (12)

MMF (Cellcept)

23 % (8)

MMF (Myfortic)

26 % (9)

GC (Prednisolon)

43 % (15)